Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14.05.CDMO Famar expands reach in Europe with acquisition of sterile manufacturing plant in Germany
13.05.Organon taps into 'romantasy' craze with new Nexplanon ad
13.05.As Bayer's restructuring rolls on, Kerendia and Nubeqa power pharma unit to surprising sales increase
13.05.Roche spotlights Perjeta's staying power with 10-year breast cancer survival results
13.05.Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah
13.05.Mayne hit by misleading drug safety claims from the FDA ahead of $430M buyout
13.05.Bluebird bio warns of potential bankruptcy after another buyout delay
13.05.Novo heads to regulators after Sogroya matches predecessor Norditropin in 3 pediatric growth disorders
12.05.Madrigal touts biomarker data in key MASH population as it works to grow Rezdiffra's reach
12.05.Medtronic activates Star power, tapping TV personality to get women discussing heart health
12.05.Trump signs sweeping executive order to cut US drug prices by 'up to 90%'
12.05.Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer
12.05.Roche gets to work on US investment plan with reveal of $700M obesity drug plant in North Carolina
12.05.AbbVie remains king in doctors' perception of immunology drugmakers, but J&J regains some ground
12.05.FDA, CDC call for pause of chikungunya shot rollout in older adults
12.05.Abeona nets $155M with FDA voucher sale just 2 weeks after gene therapy approval
09.05.Verastem scores FDA nod for first-of-its-kind oral combination to treat rare form of ovarian cancer
09.05.AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer patients
09.05.Roche pledges nearly $300M to establish new Vabysmo production plant in China
08.05.Argenx brews up DTC push for Vyvgart Hytrulo prefilled syringe in generalized myasthenia gravis
08.05.FDA misses another approval decision target date, this time for GSK's Nucala in COPD
08.05.In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
08.05.Trump to sign 'most favored nation' executive order to slash drug prices for Medicare: Politico
08.05.Takeda looks toward 'inflection point' as it eyes new launches to shake off Vyvanse generic impacts
08.05.Amneal bolsters US manufacturing capacity with Apiject collaboration deal